The investigators conducted a randomized controlled trial to reveal the effect of tDCS on negative symptoms in patients with schizophrenia and its underlying mechanism using the neuroimaging and electrophysiology.
The project will investigate the use of a novel technique, transcranial direct current stimulation (tDCS) in the treatment of patients with schizophrenia. tDCS permit the application of an extremely weak continuous electrical current to the brain through an anode and a cathode applied on the scalp. Anodal stimulation appears to increase brain activity whereas cathodal stimulation has the opposite effect. Using anodal and cathodal tDCS the investigators aimed to treat negative symptoms of schizophrenia. The investigators plan to apply tDCS such that it can simultaneously increased activity in the frontal brain areas and reduce activity over temporoparietal cortex, 2 areas involved in the physiopathology of the disease. Real active stimulation will be compare to a sham condition in 44 patients (22 in each group). 44 patients will be included in Seoul National University Hospital
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Transcranial direct current stimulation (tDCS) is a form of neurostimulation that uses constant, low direct current delivered via electrodes on the head. It can be contrasted with cranial electrotherapy stimulation, which generally uses alternating current the same way
Seoul National University Hospital
Seoul, South Korea
Positive and Negative Syndrome Scale (PANSS)
changes in psychopathology To assess a patient using PANSS, an approximately 45-minute clinical interview is conducted. The patient is rated from 1 to 7 on 30 different symptoms based on the interview as well as reports of family members or primary care hospital workers
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
The Clinical Assessment Interview for Negative Symptoms (CAINS)
changes in psychopathology The CAINS is a clinical rating scale for negative symptoms with potent and clear treatment targets for the next generation of pharmacological and psychosocial treatments. It rangs between 0 to 52
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
Electroencephalography - resting
changes in lagged phase synchronization and microstate connectivity
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
Electroencephalography - P300
changes in P300
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
Electroencephalography - MMN
changes in MMN
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
Electroencephalography - ERN
changes in ERN
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
MRI - grey matter volume
change in grey matter volume
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
MRI - cortical thickness
change in cortical thickness
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
MRI - cortical surface area
changes in MRI - cortical thickness
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
MRI - cortical gyrification
changes in cortical gyrification
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
DTI - mean diffusivity (MD)
changes in MD
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
DTI - axial diffusivity (AD)
changes in AD
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
DTI - radial diffusivity (RD)
changes in RD
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
DTI - fractional anisotropy (FA)
changes in FA
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
MRI - rsfMRI
change in BOLD signals
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
MRI - MRS
Changes in concentration of N-Acetyl Aspartate, Creatin, Choline, Myoinositol, Glutamate, Glutamine, GABA metabolite concentration change with treatment
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
fNIRS
change in level of the Oxy-Hemoglobin
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
Korean Wechsler Adult Intelligence Scale (K-WAIS)
baseline total Intelligence quotient value
Time frame: baseline
Spatial Working Memory
changes in the spatial working memory ability
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
California Verbal Learning Test
changes in verbal learning ability
Time frame: approximately 2 weeks (baseline and 2 weeks followups)
Letter/Category fluency test
changes in fluency ability
Time frame: approximately 2 weeks (baseline and 2 weeks followups)